Research & Development Partner for Viral Vaccines and Biopharmaceuticals (CRIVB-Panamá)

The Center for Research and Innovation in Vaccines and Biopharmaceuticals (CRIVB) is an emerging institution dedicated to advancing public health through innovative biotechnological solutions. We are currently looking to join international consortia under the Horizon Europe framework as a strategic partner for project cooperation.

We specialize in the early-stage development and research of prophylactic and therapeutic solutions for viruses of significant medical and epidemiological importance, including:

• Respiratory Viruses: Respiratory Syncytial Virus (RSV) and Influenza (FLU).

• Arboviruses: Dengue, Zika, and Chikungunya.

• Biopharmaceuticals: Development of monoclonal antibodies and recombinant proteins.

we offer to a Consortium:

• A multidisciplinary team focused on molecular biology, virology, and bioprocesses.

• Expertise in viral strains and epidemiological contexts specific to our region (essential for global health calls).

• As a new and growing center, we offer high flexibility, dedicated commitment to project milestones, and a strong interest in knowledge transfer and co-authorship.

• Access to newly equipped laboratory spaces designed for biotechnological innovation.

We are seeking partners (universities, R&D centers, and SMEs) who are leading proposals in vaccine platforms, adjuvant development, or antiviral therapies and require a reliable partner for testing, validation, or regional implementation.